By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. (TENX)

NASDAQ Currency in USD
$6.14
+$0.02
+0.33%
Last Update: 11 Sept 2025, 20:00
$28.01M
Market Cap
-2.39
P/E Ratio (TTM)
Forward Dividend Yield
$3.25 - $7.89
52 Week Range

TENX Stock Price Chart

Explore Tenax Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TENX price movements and trends.

TENX Company Profile

Discover essential business fundamentals and corporate details for Tenax Therapeutics, Inc. (TENX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

4 Apr 1994

Employees

4.00

CEO

Christopher T. Giordano

Description

Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. It develops TNX-103 and TNX-102 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

TENX Financial Timeline

Browse a chronological timeline of Tenax Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 12 May 2026

Upcoming earnings on 12 Nov 2025

EPS estimate is -$1.33.

Earnings released on 13 Aug 2025

EPS came in at -$0.27 surpassing the estimated -$0.50 by +46.00%.

Earnings released on 14 May 2025

EPS came in at -$0.28 surpassing the estimated -$0.48 by +41.67%.

Earnings released on 25 Mar 2025

EPS came in at -$0.18 surpassing the estimated -$0.52 by +65.38%.

Earnings released on 13 Nov 2024

EPS came in at -$0.19 surpassing the estimated -$1.38 by +86.23%.

Earnings released on 13 Aug 2024

EPS came in at -$1.83 surpassing the estimated -$1.99 by +8.04%.

Earnings released on 14 May 2024

EPS came in at -$3.12 falling short of the estimated -$2.40 by -30.00%.

Earnings released on 28 Mar 2024

EPS came in at -$12.98 falling short of the estimated -$8.14 by -59.46%, while revenue for the quarter reached $5.79K .

Stock split effective on 3 Jan 2024

Shares were split 1 : 80 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 13 Nov 2023

EPS came in at -$6.40 surpassing the estimated -$7.20 by +11.11%.

Earnings released on 14 Aug 2023

EPS came in at -$4.00 falling short of the estimated -$0.10 by -3.90K%.

Earnings released on 15 May 2023

EPS came in at -$12.00 falling short of the estimated -$0.37 by -3.14K%.

Earnings released on 30 Mar 2023

EPS came in at -$1.73 surpassing the estimated -$2.28 by +24.12%.

Stock split effective on 5 Jan 2023

Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 10 Nov 2022

EPS came in at -$176.00 matching the estimated -$176.00.

Earnings released on 11 Aug 2022

EPS came in at -$176.00 falling short of the estimated -$144.00 by -22.22%.

Earnings released on 16 May 2022

EPS came in at -$176.00 falling short of the estimated -$144.00 by -22.22%.

Earnings released on 31 Mar 2022

EPS came in at -$0.80 surpassing the estimated -$3.20 by +75.00%.

Earnings released on 16 Nov 2021

EPS came in at -$240.00 falling short of the estimated -$208.00 by -15.38%.

Earnings released on 16 Aug 2021

EPS came in at -$160.00 falling short of the estimated -$0.13 by -122.98K%.

Earnings released on 17 May 2021

EPS came in at -$2.62K falling short of the estimated -$336.00 by -680.95%.

Earnings released on 31 Mar 2021

EPS came in at -$960.00 falling short of the estimated -$288.00 by -233.33%.

Earnings released on 16 Nov 2020

EPS came in at -$288.00 falling short of the estimated -$208.00 by -38.46%.

TENX Stock Performance

Access detailed TENX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run